{
  "meta": {
    "timestamp": "2025-01-06T11:31:42.302460",
    "version": "1.0",
    "type": "search_analysis"
  },
  "companies": [
    {
      "company_name": "Nautilus Biotechnology Inc",
      "symbol": "NAUT",
      "analysis": {
        "historical": {
          "risk_score": 70,
          "key_risks": [
            "Technological validation and competition from established players",
            "Financial sustainability and slow revenue growth",
            "Market adoption risks and challenges in transitioning from established methods",
            "Regulatory and ethical concerns regarding data privacy and interpretation of complex biological information"
          ],
          "controversies": [
            "Goldman Sachs downgraded Nautilus to 'Sell' due to increased competition and slower-than-expected adoption of its technology"
          ],
          "environmental_issues": [],
          "social_issues": [
            "Potential ethical concerns related to the use of advanced proteomics data in clinical applications"
          ],
          "governance_issues": [
            "High insider ownership (32%) raising concerns about over-reliance on internal stakeholders for strategic direction"
          ],
          "recommendation": "caution",
          "confidence_score": 75
        },
        "evidence": {
          "sources": [
            {
              "url": "",
              "title": "Nautilus Biotechnology Inc, NAUT:NSQ profile - FT.com - Financial Times",
              "snippet": "Nautilus Biotechnology Inc 2701 Eastlake Ave East SEATTLE 98102 United States USA; Phone +1 (206) 333-2001; Fax +1 ... Revenue (YOY change %) Revenue (5 yr growth rate) Net income (YOY change %) Net income (5 yr growth rate) ... Comprehensive Financial Management LLC (California) as of 30 Sep 2024: 2.21m:",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Nautilus Biotechnology Inc Nautilus Biotechnology Inc financial performance and revenue growth",
              "retrieved_at": "2025-01-06T18:31:14.890188+00:00",
              "published_date": null,
              "source_hash": "8310ff4b38c96fca1b4b88200ab2053e"
            },
            {
              "url": "",
              "title": "Nautilus Biotechnology, Inc. (NAUT) - Stock Analysis",
              "snippet": "Get a real-time Nautilus Biotechnology, Inc. (NAUT) stock price quote with breaking news, financials, statistics, charts and more. ... Financial Performance. Financial Statements. Analyst Forecast. ... Nautilus Biotechnology Reports Second Quarter 2024 Financial Results. SEATTLE, July 30, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Nautilus Biotechnology Inc Nautilus Biotechnology Inc financial performance and revenue growth",
              "retrieved_at": "2025-01-06T18:31:14.890241+00:00",
              "published_date": null,
              "source_hash": "5d921ee9a4a401f032863c00c3e50b92"
            },
            {
              "url": "",
              "title": "Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year ... - Nasdaq",
              "snippet": "--Nautilus Biotechnology, Inc., a company pioneering a single molecule proteome analysis platform, today reported financial results for the fourth quarter and fiscal year ended December 31, 2023 ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Nautilus Biotechnology Inc Nautilus Biotechnology Inc financial performance and revenue growth",
              "retrieved_at": "2025-01-06T18:31:14.890256+00:00",
              "published_date": null,
              "source_hash": "1d36280fb2dade97c5fd8210c36b80f6"
            },
            {
              "url": "",
              "title": "Barclays PLC Acquires 47,059 Shares of Nautilus Biotechnology, Inc ...",
              "snippet": "Nautilus Biotechnology Trading Down 1.2 %. NASDAQ NAUT opened at $1.67 on Monday. The firm has a market capitalization of $209.69 million, a price-to-earnings ratio of -2.98 and a beta of 1.14.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Nautilus Biotechnology Inc Nautilus Biotechnology Inc competition and market positioning in proteomics",
              "retrieved_at": "2025-01-06T18:31:22.691434+00:00",
              "published_date": null,
              "source_hash": "af39989db7a9d72b97594754873f666e"
            },
            {
              "url": "",
              "title": "Nautilus Biotechnology NasdaqGS:NAUT Stock Report - Simply Wall St",
              "snippet": "2 Future Growth; 3 Past Performance; 4 Financial Health; 5 Dividend; 6 Management; 7 Ownership; Other Information; ... Nautilus Biotechnology, Inc. is covered by 8 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Nautilus Biotechnology Inc Nautilus Biotechnology Inc financial performance and revenue growth",
              "retrieved_at": "2025-01-06T18:31:14.890279+00:00",
              "published_date": null,
              "source_hash": "3a92b93bdc5744b055bb07462f11e88b"
            },
            {
              "url": "",
              "title": "Nautilus Biotechnology, Inc. (NAUT) Statistics & Valuation Metrics ...",
              "snippet": "Detailed statistics for Nautilus Biotechnology, Inc. (NAUT) stock, including valuation metrics, financial numbers, share information and more. Detailed statistics for Nautilus Biotechnology, Inc. (NAUT) stock, including valuation metrics, financial numbers, share information and more. ... Revenue Growth Forecast (5Y) n/a: EPS Growth Forecast ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Nautilus Biotechnology Inc Nautilus Biotechnology Inc financial performance and revenue growth",
              "retrieved_at": "2025-01-06T18:31:14.890290+00:00",
              "published_date": null,
              "source_hash": "9d87c96790b5cd9a671e1a1c0148f8bb"
            },
            {
              "url": "",
              "title": "Nautilus Biotechnology, Inc. (NAUT) Company Profile & Overview - Stock ...",
              "snippet": "Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Nautilus Biotechnology Inc Nautilus Biotechnology Inc competition and market positioning in proteomics",
              "retrieved_at": "2025-01-06T18:31:22.691477+00:00",
              "published_date": null,
              "source_hash": "66ead947c4293d129dffc184f416a46b"
            },
            {
              "url": "",
              "title": "Nautilus Biotechnology Reports Third Quarter 2024 Financial Results",
              "snippet": "Nautilus will host a conference call to discuss the third quarter 2024 financial results, business developments and outlook before market open on Tuesday, October 29, 2024, at 5:30 AM Pacific Time ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Nautilus Biotechnology Inc Nautilus Biotechnology Inc financial performance and revenue growth",
              "retrieved_at": "2025-01-06T18:31:14.890310+00:00",
              "published_date": null,
              "source_hash": "2e3e5902b49e6fdfef25d9be48b5bca9"
            },
            {
              "url": "",
              "title": "Nautilus Biotechnology Inc NAUT Overview - U.S. News",
              "snippet": "Nautilus Biotechnology, Inc. is a life sciences company, which engages in the development of a proteomics platform for analyzing and quantifying the human proteome. Its products include Proteome ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Nautilus Biotechnology Inc Nautilus Biotechnology Inc financial performance and revenue growth",
              "retrieved_at": "2025-01-06T18:31:14.890320+00:00",
              "published_date": null,
              "source_hash": "c6351dffbf8884f975de63ddd8821741"
            },
            {
              "url": "",
              "title": "Nautilus Biotechnology Company Profile 2024: Stock Performance ...",
              "snippet": "Nautilus Biotechnology Stock Performance. As of 13-Dec-2024, Nautilus Biotechnology's stock price is $1.95. ... $245M: 126M: 108K-$0.56: Nautilus Biotechnology Financials Summary. As of 30-Sep-2024, Nautilus Biotechnology has a trailing 12-month revenue of null. In Thousands, USD TTM 30-Sep-2024 FY 2023 31 ... PitchBook's non-financial ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Nautilus Biotechnology Inc Nautilus Biotechnology Inc financial performance and revenue growth",
              "retrieved_at": "2025-01-06T18:31:14.890329+00:00",
              "published_date": null,
              "source_hash": "82694d14ede6da6b83cea4a820bb14c6"
            },
            {
              "url": "",
              "title": "With 32% ownership, Nautilus Biotechnology, Inc. (NASDAQ:NAUT) insiders have a lot riding on the company's future",
              "snippet": "If you want to know who really controls Nautilus Biotechnology, Inc. (NASDAQ ... without a history of growth. You can see Nautilus Biotechnology's historic earnings and revenue below, but keep ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Nautilus Biotechnology Inc Nautilus Biotechnology Inc financial performance and revenue growth",
              "retrieved_at": "2025-01-06T18:31:17.139901+00:00",
              "published_date": "2024-12-08T23:59:00+00:00",
              "source_hash": "6e31cef561fb49c8d942d4613e21b6b0"
            },
            {
              "url": "",
              "title": "Nautilus Biotechnology downgraded to Sell from Neutral at Goldman Sachs",
              "snippet": "Goldman Sachs analyst Matthew Sykes downgraded Nautilus Biotechnology (NAUT ... multi-award winning platform ranks financial experts based on measured performance and the accuracy of their ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Nautilus Biotechnology Inc Nautilus Biotechnology Inc financial performance and revenue growth",
              "retrieved_at": "2025-01-06T18:31:17.140008+00:00",
              "published_date": "2024-12-05T10:15:00+00:00",
              "source_hash": "b78c7f86aeb98bcfdf31a30e5cba1aca"
            },
            {
              "url": "",
              "title": "Goldman Sachs Downgrades Nautilus Biotechnology (NAUT)",
              "snippet": "The projected annual revenue for Nautilus Biotechnology is 22MM ... No change in the last quarter. Comprehensive Financial Management holds 2,208K shares representing 1.76% ownership of the ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Nautilus Biotechnology Inc Nautilus Biotechnology Inc financial performance and revenue growth",
              "retrieved_at": "2025-01-06T18:31:17.140037+00:00",
              "published_date": "2024-12-06T06:18:00+00:00",
              "source_hash": "a4fad27415fdae144e7f5e561ea1e77e"
            },
            {
              "url": "",
              "title": "Nautilus Biotechnology Inc Ordinary Shares",
              "snippet": "We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Nautilus Biotechnology Inc Nautilus Biotechnology Inc financial performance and revenue growth",
              "retrieved_at": "2025-01-06T18:31:17.140062+00:00",
              "published_date": "2024-12-11T00:00:00+00:00",
              "source_hash": "ad2f51051c9ebc7986e01e9e1b416174"
            },
            {
              "url": "",
              "title": "Goldman Sachs cuts Nautilus Biotechnology stock to sell",
              "snippet": "The revised price target reflects the analyst's outlook on Nautilus Biotechnology's stock performance ... financial health scores and expert insights. In other recent news, Nautilus, Inc ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Nautilus Biotechnology Inc Nautilus Biotechnology Inc financial performance and revenue growth",
              "retrieved_at": "2025-01-06T18:31:17.140084+00:00",
              "published_date": "2024-12-05T06:12:00+00:00",
              "source_hash": "cd4051088aac1a0cca2e7f359545d7c4"
            },
            {
              "url": "",
              "title": "Company ~ Nautilus Biotechnology",
              "snippet": "We were founded in 2016 on the belief that incremental advancements to existing technologies are inadequate; that a bold scientific leap is required to radically reinvent proteomics and create a new gold standard in the field. Nautilus exists to pursue deep, hard science and, ultimately, to positively impact the health of millions around the world.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Nautilus Biotechnology Inc Nautilus Biotechnology Inc data privacy and ethical concerns in proteomics",
              "retrieved_at": "2025-01-06T18:31:19.045290+00:00",
              "published_date": null,
              "source_hash": "1770676ec44b8f211e9554f8c8eb6c0a"
            },
            {
              "url": "",
              "title": "Nautilus Biotechnology, Inc. (NAUT) - Stock Analysis",
              "snippet": "Nautilus Biotechnology, Inc. (NAUT) Q2 2024 Earnings Call Transcript. Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q2 2024 Earnings Conference Call July 30, 2024 8:30 AM ET Company Participants Ji-Yon Yi - Investor Relations Sujal Patel - Co-Founder & Chief Executive Off...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Nautilus Biotechnology Inc Nautilus Biotechnology Inc data privacy and ethical concerns in proteomics",
              "retrieved_at": "2025-01-06T18:31:19.045317+00:00",
              "published_date": null,
              "source_hash": "c825202a0984d5a07ae982b789b6604f"
            },
            {
              "url": "",
              "title": "Nautilus Biotechnology",
              "snippet": "Proteins and their diverse single-molecule proteoforms drive biology, but proteomics tools for measuring them are inaccessible to most labs. To help researchers understand how biology works at a mechanistic level, we plan to democratize proteomics with integrated, accessible workflows, straightforward data, and a suite of cloud-based analysis tools that will enable researchers in any field to ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Nautilus Biotechnology Inc Nautilus Biotechnology Inc data privacy and ethical concerns in proteomics",
              "retrieved_at": "2025-01-06T18:31:19.045327+00:00",
              "published_date": null,
              "source_hash": "99cbede730321c8460bd13f1afc03a58"
            },
            {
              "url": "",
              "title": "Nautilus Biotechnology, Inc. (NAUT) - Yahoo Finance",
              "snippet": "Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington. Corporate Governance Nautilus Biotechnology, Inc.'s ISS Governance QualityScore as of January 1 ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Nautilus Biotechnology Inc Nautilus Biotechnology Inc data privacy and ethical concerns in proteomics",
              "retrieved_at": "2025-01-06T18:31:19.045337+00:00",
              "published_date": null,
              "source_hash": "a6504703aba533e6fcb616b3f0da684a"
            },
            {
              "url": "",
              "title": "Nautilus Biotechnology, Inc. - AnnualReports.com",
              "snippet": "Nautilus' mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental ... Visit website. Nautilus Biotechnology, Inc. Most Recent Annual Report. MOST RECENT 2023 Annual Report and Form 10K. View PDF View Form 10K (HTML) Older/Archived Annual Reports. 2022 Annual Report View Annual Report ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Nautilus Biotechnology Inc Nautilus Biotechnology Inc competition and market positioning in proteomics",
              "retrieved_at": "2025-01-06T18:31:22.691489+00:00",
              "published_date": null,
              "source_hash": "c36660c8b117f0120b8c8ddb2a0dda3c"
            },
            {
              "url": "",
              "title": "Nautilus Biotechnology Faces ESG Challenges Amid Regulatory ... - Nasdaq",
              "snippet": "Nautilus Biotechnology, Inc. faces heightened scrutiny regarding its environmental, social, and governance (ESG) responsibilities, which poses significant risks and could lead to increased costs.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Nautilus Biotechnology Inc Nautilus Biotechnology Inc data privacy and ethical concerns in proteomics",
              "retrieved_at": "2025-01-06T18:31:19.045358+00:00",
              "published_date": null,
              "source_hash": "615f01398db2ab8e191bd8e560b38109"
            },
            {
              "url": "",
              "title": "Nautilus Biotechnology Inc (NAUT) Q3 2024 Earnings Call Highlights ...",
              "snippet": "Nautilus Biotechnology Inc (NASDAQ:NAUT) faces potential challenges in breaking into the market with established players like Astral and Ultra 2, which have gained traction in the proteomics space ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Nautilus Biotechnology Inc Nautilus Biotechnology Inc competition and market positioning in proteomics",
              "retrieved_at": "2025-01-06T18:31:22.691324+00:00",
              "published_date": null,
              "source_hash": "0a86b302d917dda9fd1db480edde3b21"
            },
            {
              "url": "",
              "title": "Nautilus Biotechnology Inc Registered Shs - Markets Insider",
              "snippet": "Nautilus Biotechnology, Inc. is a life sciences company, which engages in the development of a proteomics platform for analyzing and quantifying the human proteome.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Nautilus Biotechnology Inc Nautilus Biotechnology Inc data privacy and ethical concerns in proteomics",
              "retrieved_at": "2025-01-06T18:31:19.045378+00:00",
              "published_date": null,
              "source_hash": "1bc11bf5ccd98c024dcd26faf0bf0878"
            },
            {
              "url": "",
              "title": "With 32% ownership, Nautilus Biotechnology, Inc. (NASDAQ:NAUT) insiders have a lot riding on the company's future",
              "snippet": "If you want to know who really controls Nautilus Biotechnology, Inc. (NASDAQ:NAUT), then you ... many shares in Nautilus Biotechnology. Our data suggests that Parag Mallick, who is also the ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Nautilus Biotechnology Inc Nautilus Biotechnology Inc data privacy and ethical concerns in proteomics",
              "retrieved_at": "2025-01-06T18:31:21.186138+00:00",
              "published_date": "2024-12-08T23:59:00+00:00",
              "source_hash": "6c2ed48983d73cb0373bc0b115c95eb4"
            },
            {
              "url": "",
              "title": "Nautilus Biotechnology downgraded to Sell from Neutral at Goldman Sachs",
              "snippet": "Goldman Sachs analyst Matthew Sykes downgraded Nautilus Biotechnology (NAUT ... The firm believes the market for discovery proteomics has become more competitive with innovation from mass spec ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Nautilus Biotechnology Inc Nautilus Biotechnology Inc competition and market positioning in proteomics",
              "retrieved_at": "2025-01-06T18:31:25.441719+00:00",
              "published_date": "2024-12-05T10:15:00+00:00",
              "source_hash": "efdcf72d02a2e10cca81778563618e89"
            },
            {
              "url": "",
              "title": "MetLife Investment Management LLC Acquires Shares of 30,613 Nautilus Biotechnology, Inc. (NASDAQ:NAUT)",
              "snippet": "MetLife Investment Management LLC acquired a new stake in shares of Nautilus Biotechnology, Inc. (NASDAQ ... company develops Nautilus Platform, a proteomics platform that includes end-to-end ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Nautilus Biotechnology Inc Nautilus Biotechnology Inc competition and market positioning in proteomics",
              "retrieved_at": "2025-01-06T18:31:25.441749+00:00",
              "published_date": "2024-12-11T00:00:00+00:00",
              "source_hash": "84831e09cce034fd51ffabc09f902ee8"
            },
            {
              "url": "",
              "title": "Nautilus Biotechnology Inc.",
              "snippet": "Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Nautilus Biotechnology Inc Nautilus Biotechnology Inc data privacy and ethical concerns in proteomics",
              "retrieved_at": "2025-01-06T18:31:21.186303+00:00",
              "published_date": "2024-09-15T06:47:00+00:00",
              "source_hash": "ac63f68725a21630a70c0532fde739c4"
            },
            {
              "url": "",
              "title": "Nautilus Biotechnology, Inc. (NAUT)",
              "snippet": "Reveal insider sentiment with alternative data that tracks buy and sell trades made by top managers and company directors.",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Nautilus Biotechnology Inc Nautilus Biotechnology Inc data privacy and ethical concerns in proteomics",
              "retrieved_at": "2025-01-06T18:31:21.186327+00:00",
              "published_date": "2024-04-11T21:29:00+00:00",
              "source_hash": "9545c9c1870a4c3de1cab11257fbac70"
            },
            {
              "url": "",
              "title": "Q3 2024 Nautilus Biotechnology Inc Earnings Call - Yahoo Finance",
              "snippet": "Q3 2024 Nautilus Biotechnology Inc Earnings Call ... to advances in the relationship between proteomics and artificial intelligence. ... Ken Suzuki to Nautilus as our first Chief Marketing Officer ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Nautilus Biotechnology Inc Nautilus Biotechnology Inc competition and market positioning in proteomics",
              "retrieved_at": "2025-01-06T18:31:22.691455+00:00",
              "published_date": null,
              "source_hash": "878c734461eb4dea157e47174adbb437"
            },
            {
              "url": "",
              "title": "Nautilus Biotechnology, Inc. (NAUT) - Stock Analysis",
              "snippet": "Nautilus Biotechnology, Inc. (NAUT) Q3 2023 Earnings Call Transcript. Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q3 2023 Earnings Conference Call October 31, 2023 8:30 AM ET Company Participants Carrie Mendivil - IR Sujal Patel - Co-Founder & CEO Parag Mallick - Co-Fou...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Nautilus Biotechnology Inc Nautilus Biotechnology Inc competition and market positioning in proteomics",
              "retrieved_at": "2025-01-06T18:31:22.691466+00:00",
              "published_date": null,
              "source_hash": "4ccafe50861d3f6918fe791c745b68a3"
            },
            {
              "url": "",
              "title": "Nautilus Biotechnology (NAUT) Stock Price, News & Analysis - MarketBeat",
              "snippet": "Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Nautilus Biotechnology Inc Nautilus Biotechnology Inc competition and market positioning in proteomics",
              "retrieved_at": "2025-01-06T18:31:22.691501+00:00",
              "published_date": null,
              "source_hash": "6885dc9960f89f8a095487b4686941f7"
            },
            {
              "url": "",
              "title": "Next-Gen Proteomics Company Nautilus Biotechnology to List on ... - Nasdaq",
              "snippet": "Nautilus Biotechnology Media: Chris Blessington Vice President, Corporate Marketing and Communications chrisb@nautilus.bio Source: Nautilus Biotechnology, Inc. In This Story",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Nautilus Biotechnology Inc Nautilus Biotechnology Inc competition and market positioning in proteomics",
              "retrieved_at": "2025-01-06T18:31:22.691511+00:00",
              "published_date": null,
              "source_hash": "75a9236423ad42135326e6c4354832ff"
            },
            {
              "url": "",
              "title": "Nautilus Biotechnology Faces ESG Challenges Amid Regulatory ... - Nasdaq",
              "snippet": "A misstep in these areas could adversely impact Nautilus Biotechnology's business performance and growth prospects.The average NAUT stock price target is $5.00, implying 88.68% upside potential ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Nautilus Biotechnology Inc Nautilus Biotechnology Inc competition and market positioning in proteomics",
              "retrieved_at": "2025-01-06T18:31:22.691523+00:00",
              "published_date": null,
              "source_hash": "41ddb7b157f819a5b0f477fec5b2dabb"
            },
            {
              "url": "",
              "title": "Proteomics Company Nautilus Bio to List on NASDAQ via SPAC",
              "snippet": "On February 8th, Arya III, a special purpose acquisition company (SPAC), announced entering into a combination agreement with Seattle-based Nautilus Biotechnology and expect to be listed on NASDAQ under the ticker symbol \"NAUT.\" Nautilus, founded in 2016, will be relocated to Delaware for its official state of incorporation as part of its going public. The combined company, which has ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Nautilus Biotechnology Inc Nautilus Biotechnology Inc competition and market positioning in proteomics",
              "retrieved_at": "2025-01-06T18:31:22.691532+00:00",
              "published_date": null,
              "source_hash": "37d4d58d8c9bb6376cd99c13e03b35d9"
            },
            {
              "url": "",
              "title": "With 32% ownership, Nautilus Biotechnology, Inc. (NASDAQ:NAUT) insiders have a lot riding on the company's future",
              "snippet": "If you want to know who really controls Nautilus Biotechnology, Inc. (NASDAQ:NAUT), then you ... against an index that approximates the local market. So they usually pay more attention to ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Nautilus Biotechnology Inc Nautilus Biotechnology Inc competition and market positioning in proteomics",
              "retrieved_at": "2025-01-06T18:31:25.441616+00:00",
              "published_date": "2024-12-08T23:59:00+00:00",
              "source_hash": "eba2e04d58490d2693617a1d59773b55"
            },
            {
              "url": "",
              "title": "Goldman Sachs cuts Nautilus Biotechnology stock to sell",
              "snippet": "Nautilus Biotechnology, which had aimed to address the high-throughput and broadscale coverage needs within the proteomics market ... Nautilus, Inc. disclosed its Q3 2024 earnings results ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Nautilus Biotechnology Inc Nautilus Biotechnology Inc competition and market positioning in proteomics",
              "retrieved_at": "2025-01-06T18:31:25.441776+00:00",
              "published_date": "2024-12-05T06:12:00+00:00",
              "source_hash": "108660928a201a056ab629da3bd6152f"
            },
            {
              "url": "",
              "title": "Nautilus Biotechnology Inc.",
              "snippet": "Market Capitalization Reflects the total market value of a company. Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. For companies with multiple ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Nautilus Biotechnology Inc Nautilus Biotechnology Inc competition and market positioning in proteomics",
              "retrieved_at": "2025-01-06T18:31:25.441798+00:00",
              "published_date": "2024-12-13T00:00:00+00:00",
              "source_hash": "b56c636239d360e63df40a34eceaaff4"
            }
          ],
          "queries": [
            {
              "category": "financial_legal",
              "query": "Nautilus Biotechnology Inc financial performance and revenue growth",
              "rationale": "Assess the company's financial sustainability and ability to commercialize its platform",
              "priority": 1
            },
            {
              "category": "ethical_social",
              "query": "Nautilus Biotechnology Inc data privacy and ethical concerns in proteomics",
              "rationale": "Investigate potential ethical and regulatory issues related to the use of advanced proteomics data in clinical applications",
              "priority": 2
            },
            {
              "category": "financial_legal",
              "query": "Nautilus Biotechnology Inc competition and market positioning in proteomics",
              "rationale": "Evaluate the competitive landscape and potential risks from established players in proteomics and adjacent fields",
              "priority": 3
            }
          ]
        },
        "categorization": {
          "product_issues": [],
          "conduct_issues": [],
          "tags": [],
          "patterns": {}
        }
      },
      "metadata": {
        "analysis_timestamp": "2025-01-06T11:31:42.302468",
        "data_confidence": 75,
        "pattern_confidence": null
      }
    }
  ]
}